4SC
Planegg · Founded 1997
About 4SC
4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious, and provide a better quality of life.
Company Facts
- Founded: 1997
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $101.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2019)
- Ticker: fra:VSC
- Website: 4sc.de
- Phone: +490897007630
Industries & Categories
Biopharma, Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/4sc-129101 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.